MYC and ovarian cancer: All of these results indicated that this acceleratory effect of HK2 on promoting cell cycle progression in this study likely attributed to the induction of c-myc and CyclinD1 expression through Wnt/β-catenin signaling pathway in ovarian cancer cells.